U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844785) titled 'Metabolic and Hormonal Parameters in Women With Polyendocrine Metabolic Ovarian Syndrome' on Aug. 10.
Brief Summary: Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a common endocrine and metabolic disorder associated with insulin resistance, hyperandrogenism, and an increased risk of long-term metabolic complications. Fetuin-A and resistin are adipokines implicated in insulin resistance and chronic inflammation and may serve as potential biomarkers for metabolic dysfunction in women with PMOS.
This prospective observational case-control study aims to compare serum and salivary Fetuin-A and resistin levels between women with PM...